Foxp3+ regulatory T cells in the control of experimental CNS autoimmune disease

Journal of Neuroimmunology

Volumn 193, Issue 1-2, 2008, Pages 1-11

  O'Connor, Richard A ^a   Anderton, Stephen M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Autoimmunity; Immunotherapy; Multiple sclerosis; T regulatory cells; Tolerance

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNE DISEASE; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; REGULATORY T LYMPHOCYTE; REVIEW; SUPPRESSOR CELL;

ANIMALS; ANTIGENS, CD; BRAIN; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MULTIPLE SCLEROSIS; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, CELL SURFACE; T-LYMPHOCYTES, REGULATORY;

EID: 37849027594     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.11.016     Document Type: Review

References (112)

1. Adda D.H., Beraud E., and Depieds R. Evidence for suppressor cells in Lewis rats' experimental allergic encephalomyelitis. Eur. J. Immunol. 7 (1977) 620-623
2. Akdis C.A., Blesken T., Akdis M., Wuthrich B., and Blaser K. Role of interleukin 10 in specific immunotherapy. J. Clin. Invest. 102 (1998) 98-106
3. Anderton S.M. Peptide-based immunotherapy of autoimmunity: a path of puzzles, paradoxes and possibilities. Immunology 104 (2001) 367-376
4. Anderton S.M. Avoiding autoimmune disease - T cells know their limits. Trends Immunol. 27 (2006) 208-214
5. Anderton S.M., and Wraith D.C. Hierarchy in the ability of T cell epitopes to induce peripheral tolerance to antigens from myelin. Eur. J. Immunol. 28 (1998) 1251-1261
6. Anderton S., Burkhart C., Metzler B., and Wraith D. Mechanisms of central and peripheral T-cell tolerance: lessons from experimental models of multiple sclerosis. Immunol. Rev. 169 (1999) 123-137
7. Anderton S.M., Radu C.G., Lowrey P.A., Ward E.S., and Wraith D.C. Negative selection during the peripheral immune response to antigen. J. Exp. Med. 193 (2001) 1-11
8. Annacker O., Coombes J.L., Malmstrom V., Uhlig H.H., Bourne T., Johansson-Lindbom B., Agace W.W., Parker C.M., and Powrie F. Essential role for CD103 in the T cell-mediated regulation of experimental colitis. J. Exp. Med. 202 (2005) 1051-1061
9. Apostolou I., and von Boehmer H. In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 199 (2004) 1401-1408
10. Battaglia M., Stabilini A., Migliavacca B., Horejs-Hoeck J., Kaupper T., and Roncarolo M.G. Rapamycin promotes expansion of functional CD4+CD25 +FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J. Immunol. 177 (2006) 8338-8347
11. Bischof F., Hofmann M., Schumacher T.N.M., Vyth-Dreese F.A., Weissert R., Schild H., Kruisbeek A.M., and Melms A. Analysis of autoreactive CD4 T cells in experimental autoimmune encephalomyelitis after primary and secondary challenge using MHC class II tetramers. J. Immunol. 172 (2004) 2878-2884
12. Brideau R.J., Carter P.B., McMaster W.R., Mason D.W., and Williams A.F. Two subsets of rat T lymphocytes defined with monoclonal antibodies. Eur. J. Immunol. 10 (1980) 609-615
13. Brode S., Raine T., Zaccone P., and Cooke A. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells. J. Immunol. 177 (2006) 6603-6612
14. Burkhart C., Liu G.Y., Anderton S.M., Metzler B., and Wraith D.C. Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10. Int. Immunol. 11 (1999) 1625-1634
15. Cao D., van Vollenhoven R., Klareskog L., Trollmo C., and Malmstrom V. CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res. Ther. 6 (2004) R335-R346
16. Cao D., Borjesson O., Larsson P., Rudin A., Gunnarsson I., Klareskog L., Malmstrom V., and Trollmo C. FOXP3 identifies regulatory CD25bright CD4+ T cells in rheumatic joints. Scand. J. Immunol. 63 (2006) 444-452
17. Cassan C., Piaggio E., Zappulla J.P., Mars L.T., Couturier N., Bucciarelli F., Desbois S., Bauer J., Gonzalez-Dunia D., and Liblau R.S. Pertussis toxin reduces the number of splenic foxp3+ regulatory T cells. J. Immunol. 177 (2006) 1552-1560
18. Chatenoud L. CD3-specific antibodies restore self-tolerance: mechanisms and clinical applications. Curr. Opin. Immunol. 17 (2005) 632-637
19. Chen Y., Kuchroo V.K., Inobe J., Hafler D.A., and Weiner H.L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265 (1994) 1237-1240
20. Chen X., Oppenheim J.J., Winkler-Pickett R.T., Ortaldo J.R., and Howard O.M.Z. Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3+CD4+CD25+ T regulatory cells in vivo and enhances their capacity to suppress EAE. Eur. J. Immunol. 36 (2006) 2139-2149
21. Chen X., Winkler-Pickett R.T., Carbonetti N.H., Ortaldo J.R., Oppenheim J.J., and Howard O.M. Pertussis toxin as an adjuvant suppresses the number and function of CD4+CD25+ T regulatory cells. Eur. J. Immunol. 36 (2006) 671-680
22. Conant S.B., and Swanborg R.H. Autoreactive T cells persist in rats protected against experimental autoimmune encephalomyelitis and can be activated through stimulation of innate immunity. J. Immunol. 172 (2004) 5322-5328
23. Cua D.J., Hutchins B., LaFace D.M., Stohlman S.A., and Coffman R.L. Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis. J. Immunol. 166 (2001) 602-608
24. Davidson T.S., Dipaolo R.J., Andersson J., and Shevach E.M. Cutting edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells. J. Immunol. 178 (2007) 4022-4026
25. de Kleer I.M., Wedderburn L.R., Taams L.S., Patel A., Varsani H., Klein M., de Jager W., Pugayung G., Giannoni F., Rijkers G., Albani S., Kuis W., and Prakken B. CD4+CD25 bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J. Immunol. 172 (2004) 6435-6443
26. de Vos A.F., van Meurs M., Brok H.P., Boven L.A., Hintzen R.Q., van der Valk P., Ravid R., Rensing S., Boon L., t'Hart B.A., and Laman J.D. Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs. J. Immunol. 169 (2002) 5415-5423
27. Feger U., Luther C., Poeschel S., Melms A., Tolosa E., and Wiendl H. Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients. Clin. Exp. Immunol. 147 (2007) 412-418
28. Fernadez-Martin A., Gonzalez-Rey E., Chorny A., Ganea D., and Delgado M. Vasoactive intestinal peptide induces regulatory T cells during experimental autoimmune encephalomyelitis. Eur. J. Immunol. 36 (2006) 318-326
29. Fillatreau S., Sweenie C.H., McGeachy M.J., Gray D., and Anderton S.M. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3 (2002) 944-950
30. Fontenot J.D., Rasmussen J.P., Williams L.M., Dooley J.L., Farr A.G., and Rudensky A.Y. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22 (2005) 329-341
31. Fowell D., Powrie F., Saoudi A., Seddon B., Heath V., and Mason D. The role of subsets of CD4+ T cells in autoimmunity. Ciba Found. Symp. 195 (1995) 173-182
32. Friese M.A., Jensen L.T., Willcox N., and Fugger L. Humanized mouse models for organ-specific autoimmune diseases. Curr. Opin. Immunol. 18 (2006) 704-709
33. Fujinami R.S., and Oldstone M.B. Molecular mimicry as a mechanism for virus-induced autoimmunity. Immunol. Res. 8 (1989) 3-15
34. Gartner D., Hoff H., Gimsa U., Burmester G.R., and Brunner-Weinzierl M.C. CD25 regulatory T cells determine secondary but not primary remission in EAE: impact on long-term disease progression. J. Neuroimmunol. 172 (2006) 73-84
35. Haas J., Hug A., Viehover A., Fritzsching B., Falk C.S., Filser A., Vetter T., Milkova L., Korporal M., Fritz B., Storch-Hagenlocher B., Krammer P.H., Suri-Payer E., and Wildemann B. Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur. J. Immunol. 35 (2005) 3343-3352
36. Hatterer E., Davoust N., Didier-Bazes M., Vuaillat C., Malcus C., Belin M.F., and Nataf S. How to drain without lymphatics? Dendritic cells migrate from the cerebrospinal fluid to the B-cell follicles of cervical lymph nodes. Blood 107 (2006) 806-812
37. Hawiger D., Masilamani R.F., Bettelli E., Kuchroo V.K., and Nussenzweig M.C. Immunological unresponsiveness characterized by increased expression of CD5 on peripheral T cells induced by dendritic cells in vivo. Immunity 20 (2004) 695-705
38. Hochweller K., Sweenie C.H., and Anderton S.M. Immunological tolerance using synthetic peptides - basic mechanisms and clinical application. Curr. Mol. Med. 6 (2006) 631-643
39. Holda J.H., and Swanborg R.H. Regulation of experimental allergic encephalomyelitis. III. Demonstration of effector cells in tolerant rats. Eur. J. Immunol. 11 (1981) 338-340
40. Huehn J., Siegmund K., Lehmann J.C.U., Siewert C., Haubold U., Feuerer M., Debes G.F., Lauber J., Frey O., Przybylski G.K., Niesner U., de la Rosa M., Schmidt C.A., Brauer R., Buer J., Scheffold A., and Hamann A. Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J. Exp. Med. 199 (2004) 303-313
41. Itoh M., Takahashi T., Sakaguchi N., Kuniyasu Y., Shimizu J., Otsuka F., and Sakaguchi S. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162 (1999) 5317-5326
42. Karpus W.J., and Swanborg R.H. CD4+ suppressor cells differentially affect the production of IFN-gamma by effector cells of experimental autoimmune encephalomyelitis. J. Immunol. 143 (1989) 3492-3497
43. Karpus W.J., and Swanborg R.H. CD4+ suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-beta. J. Immunol. 146 (1991) 1163-1168
44. Karpus W.J., Gould K.E., and Swanborg R.H. CD4+ suppressor cells of autoimmune encephalomyelitis respond to T cell receptor-associated determinants on effector cells by interleukin-4 secretion. Eur. J. Immunol. 22 (1992) 1757-1763
45. Keymeulen B., Vandemeulebroucke E., Ziegler A.G., Mathieu C., Kaufman L., Hale G., Gorus F., Goldman M., Walter M., Candon S., Schandene L., Crenier L., De Block C., Seigneurin J.M., De Pauw P., Pierard D., Weets I., Rebello P., Bird P., Berrie E., Frewin M., Waldmann H., Bach J.F., Pipeleers D., and Chatenoud L. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. New Engl. J. Med. 352 (2005) 2598-2608
46. Killen J.A., and Swanborg R.H. Regulation of experimental allergic encephalomyelitis. Part 4. Further characterization of postrecovery suppressor cells. J. Neuroimmunol. 3 (1982) 159-166
47. Kim J.M., Rasmussen J.P., and Rudensky A.Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8 (2007) 191-197
48. Kohm A.P., and Miller S.D. Response to comment on "Cutting Edge: anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells". J. Immunol. 177 (2006) 2037-2038
49. Kohm A.P., Carpentier P.A., Anger H.A., and Miller S.D. Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169 (2002) 4712-4716
50. Kohm A.P., McMahon J.S., Podojil J.R., Begolka W.S., DeGutes M., Kasprowicz D.J., Ziegler S.F., and Miller S.D. Cutting edge: anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells. J. Immunol. 176 (2006) 3301-3305
51. Korn T., Reddy J., Gao W., Bettelli E., Awasthi A., Petersen T.R., Backstrom B.T., Sobel R.A., Wucherpfennig K.W., Strom T.B., Oukka M., and Kuchroo V.K. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13 (2007) 423-431
52. Kretschmer K., Apostolou I., Hawiger D., Khazaie K., Nussenzweig M.C., and von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6 (2005) 1219-1227
53. Lafaille J.J., Nagashima K., Katsuki M., and Tonegawa S. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 78 (1994) 399-408
54. Lando Z., Teitelbaum D., and Arnon R. Effect of cyclophosphamide on suppressor cell activity in mice unresponsive to EAE. J. Immunol. 123 (1979) 2156-2160
55. Larche M., and Wraith D.C. Peptide-based therapeutic vaccines for allergic and autoimmune diseases. Nat. Med. 11 (2005) S69-S76
56. Lehmann J., Huehn J., de la Rosa M., Maszyna F., Kretschmer U., Krenn V., Brunner M., Scheffold A., and Hamann A. Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25-regulatory T cells. Proc. Natl. Acad. Sci. 99 (2002) 13031-13036
57. Liu Y., Teige I., Birnir B., and Issazadeh-Navikas S. Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. Nat. Med. 12 (2006) 518-525
58. Lowenthal J.W., Corthesy P., Tougne C., Lees R., MacDonald H.R., and Nabholz M. High and low affinity IL 2 receptors: analysis by IL 2 dissociation rate and reactivity with monoclonal anti-receptor antibody PC61. J. Immunol. 135 (1985) 3988-3994
59. Mann M.K., Maresz K., Shriver L.P., Tan Y., and Dittel B.N. B cell regulation of CD4+CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. J. Immunol. 178 (2007) 3447-3456
60. Marie J.C., Letterio J.J., Gavin M., and Rudensky A.Y. TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J. Exp. Med. 201 (2005) 1061-1067
61. Masteller E.L., Warner M.R., Tang Q., Tarbell K.V., McDevitt H., and Bluestone J.A. Expansion of functional endogenous antigen-specific CD4 +CD25+ regulatory T cells from nonobese diabetic mice. J. Immunol. 175 (2005) 3053-3059
62. Mauri C., Gray D., Mushtaq N., and Londei M. Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 197 (2003) 489-501
63. McCue D., Ryan K.R., Wraith D.C., and Anderton S.M. Activation thresholds determine susceptibility to peptide-induced tolerance in a heterogeneous myelin-reactive T cell repertoire. J. Neuroimmunol. 156 (2004) 96-106
64. McDonald A.H., and Swanborg R.H. Antigen-specific inhibition of immune interferon production by suppressor cells of autoimmune encephalomyelitis. J. Immunol. 140 (1988) 1132-1138
65. McGeachy M.J., Stephens L.A., and Anderton S.M. Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system. J. Immunol. 175 (2005) 3025-3032
66. McHugh R.S., and Shevach E.M. The role of suppressor T cells in regulation of immune responses. J. Allergy Clin. Immunol 110 (2002) 693-702
67. Miller A., Lider O., Roberts A.B., Sporn M.B., and Weiner H.L. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc. Natl. Acad. Sci. USA 89 (1992) 421-425
68. Mizoguchi A., Mizoguchi E., Takedatsu H., Blumberg R.S., and Bhan A.K. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16 (2002) 219-230
69. Montero E., Nussbaum G., Kaye J.F., Perez R., Lage A., Ben-Nun A., and Cohen I.R. Regulation of experimental autoimmune encephalomyelitis by CD4+, CD25+ and CD8+ T cells: analysis using depleting antibodies. J. Autoimmun. 23 (2004) 1-7
70. Montgomery I.N., and Rauch H.C. Experimental allergic encephalomyelitis in mice: adoptive transfer of disease is modulated by the presence of natural suppressor cells. Neurochem. Res. 9 (1984) 1399-1406
71. Nicholson L.B., Greer J.M., Sobel R.A., Lees M.B., and Kuchroo V.K. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity 3 (1995) 397-405
72. Nicholson L.B., Murtaza A., Hafler B.P., Sette A., and Kuchroo V.K. A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens. Proc. Natl. Acad. Sci. USA 94 (1997) 9279-9284
73. O'Connor R.A., Malpass K.H., and Anderton S.M. The inflamed central nervous system drives the activation and rapid proliferation of Foxp3+ regulatory T cells. J. Immunol. 179 (2007) 958-966
74. Ochoa-Reparaz J., Riccardi C., Rynda A., Jun S., Callis G., and Pascual D.W. Regulatory T cell vaccination without autoantigen protects against experimental autoimmune encephalomyelitis. J. Immunol. 178 (2007) 1791-1799
75. Olivares-Villagomez D., Wang Y., and Lafaille J.J. Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J. Exp. Med. 188 (1998) 1883-1894
76. Polanczyk M.J., Hopke C., Huan J., Vandenbark A.A., and Offner H. Enhanced FoxP3 expression and Treg cell function in pregnant and estrogen-treated mice. J. Neuroimmunol. 170 (2005) 85-92
77. Radu C.G., Anderton S.M., Firan M., Wraith D.C., and Ward E.S. Detection of autoreactive T cells in H-2u mice using peptide-MHC multimers. Int. Immunol. 12 (2000) 1553-1560
78. Reddy J., Bettelli E., Nicholson L., Waldner H., Jang M.H., Wucherpfennig K.W., and Kuchroo V.K. Detection of autoreactive myelin proteolipid protein 139-151-specific T cells by using MHC II (IAs) tetramers. J. Immunol. 170 (2003) 870-877
79. Reddy J., Illes Z., Zhang X., Encinas J., Pyrdol J., Nicholson L., Sobel R.A., Wucherpfennig K.W., and Kuchroo V.K. Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U S A 101 (2004) 15434-15439
80. Reddy J., Waldner H., Zhang X., Illes Z., Wucherpfennig K.W., Sobel R.A., and Kuchroo V.K. Cutting edge: CD4+CD25+ regulatory T cells contribute to gender differences in susceptibility to experimental autoimmune encephalomyelitis. J. Immunol. 175 (2005) 5591-5595
81. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6 (2005) 345-352
82. Sakaguchi S., Fukuma K., Kuribayashi K., and Masuda T. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J. Exp. Med. 161 (1985) 72-87
83. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., and Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155 (1995) 1151-1164
84. Sedgewick J.D. Role of suppressor T cells in regulating passively induced experimental allergic encephalomyelitis. J. Immunol. 137 (1986) 1407
85. Sedgwick J.D. Long-term depletion of CD8+ T cells in vivo in the rat: no observed role for CD8+ (cytotoxic/suppressor) cells in the immunoregulation of experimental allergic encephalomyelitis. Eur. J. Immunol. 18 (1988) 495-502
86. Steinman L. A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage. Nat. Med. 13 (2007) 139-145
87. Stephens L.A., and Anderton S.M. Comment on "Cutting edge: anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells". J. Immunol. 177 (2006) 2036-2037
88. Stephens L.A., Gray D., and Anderton S.M. CD4+CD25+ regulatory T cells limit the risk of autoimmune disease arising from T cell receptor crossreactivity. Proc. Natl. Acad. Sci. USA 102 (2005) 17418-17423
89. Suri-Payer E., Amar A.Z., Thornton A.M., and Shevach E.M. CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. 160 (1998) 1212-1218
90. Swierkosz J.E., and Swanborg R.H. Suppressor cell control of unresponsiveness to experimental allergic encephalomyelitis. J. Immunol. 115 (1975) 631-633
91. Szvet-Moldavskaya I.A., and Svet-Moldavsky G.J. Aquired resistance to experimental allergic encephalomyelitis. Nature 181 (1958) 1536-1537
92. Tadashi N., Richert J.R., Driscoll B.F., Kies M.W., and Alvord E.C. Transfer of allergic encephalomyelitis with spleen cells from donors sensitized with myelin basic protein in incomplete freunds adjuvant. J. Immunol. 128 (1982) 932-934
93. Tadokoro C.E., Shakhar G., Shen S., Ding Y., Lino A.C., Maraver A., Lafaille J.J., and Dustin M.L. Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo. J. Exp. Med. 203 (2006) 505-511
94. Tang Q., Henriksen K.J., Bi M., Finger E.B., Szot G., Ye J., Masteller E.L., McDevitt H., Bonyhadi M., and Bluestone J.A. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199 (2004) 1455-1465
95. Thorstenson K.M., and Khoruts A. Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J. Immunol. 167 (2001) 188-195
96. Tischner D., Weishaupt A., Van Den Brandt J., Muller N., Beyersdorf N., Ip C.W., Toyka K.V., Hunig T., Gold R., Kerkau T., and Reichardt H.M. Polyclonal expansion of regulatory T cells interferes with effector cell migration in a model of multiple sclerosis. Brain 129 (2006) 2635-2647
97. Tsaknaridis L., Spencer L., Culbertson N., Hicks K., LaTocha D., Chou Y.K., Whitham R.H., Bakke A., Jones R.E., Offner H., Bourdette D.N., and Vandenbark A.A. Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity. J. Neurosci. Res. 74 (2003) 296-308
98. Uhlig H.H., Coombes J., Mottet C., Izcue A., Thompson C., Fanger A., Tannapfel A., Fontenot J.D., Ramsdell F., and Powrie F. Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J. Immunol. 177 (2006) 5852-5860
99. Van Amelsfort J.M.R., Jacobs K.M.G., Bijlsma J.W.J., Lafeber F.P.J.G., and Taams L.S. CD4+CD25+ regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum. 50 (2004) 2775-2785
100. Venken K., Hellings N., Hensen K., Rummens J.L., Medaer R., D'Hooghe M.B., Dubois B., Raus J., and Stinissen P. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression. J. Neurosci. Res. 83 (2006) 1432-1446
101. Verhoef A., Alexander C., Kay A.B., and Larche M. T cell epitope immunotherapy induces a CD4+ T cell population with regulatory activity. PLoS Med. 2 (2005) e78
102. Viglietta V., Baecher-Allan C., Weiner H.L., and Hafler D.A. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199 (2004) 971-979
103. von Boehmer H. Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6 (2005) 338-344
104. Waldmann H., Adams E., Fairchild P.J., and Cobbold S. Infectious tolerance and the long-term acceptance of transplanted tissue. Immunol. Rev. 212 (2006) 301-313
105. Willenborg D.O., Sjollema P., and Danta G. Immunoregulation of passively induced allergic encephalomyelitis. J. Immunol. 136 (1986) 1676-1679
106. Wolf S.D., Dittel B.N., Hardardottir F., and Janeway Jr. C.A. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 184 (1996) 2271-2278
107. Wraith D.C., Smilek D.E., Mitchell D.J., Steinman L., and McDevitt H.O. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell 59 (1989) 247-255
108. Wraith D.C., Bruun B., and Fairchild P.J. Cross-reactive antigen recognition by an encephalitogenic T cell receptor. Implications for T cell biology and autoimmunity. J. Immunol. 149 (1992) 3765-3770
109. Yu P., Gregg R.K., Bell J.J., Ellis J.S., Divekar R., Lee H.-H., Jain R., Waldner H., Hardaway J.C., Collins M., Kuchroo V.K., and Zaghouani H. Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen. J. Immunol. 174 (2005) 6772-6780
110. Zelenay S., and Demengeot J. Comment on "Cutting edge: anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells". J. Immunol. 177 (2006) 2036-a-2037
111. Zhang X., Koldzic D.N., Izikson L., Reddy J., Nazareno R.F., Sakaguchi S., Kuchroo V.K., and Weiner H.L. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Int. Immunol. 16 (2004) 249-256
112. Zhang X., Reddy J., Ochi H., Frenkel D., Kuchroo V.K., and Weiner H.L. Recovery from experimental allergic encephalomyelitis is TGF-beta dependent and associated with increases in CD4+LAP+ and CD4+CD25+ T cells. Int. Immunol. 18 (2006) 495-503